ADHD and Autism Together (AuDHD): The Co-Occurring Picture

ADHD and autism are separate diagnoses but they co-occur often. AuDHD is the community term, now used clinically too, for the picture of a person who meets criteria for both. This article covers what the co-occurrence actually looks like, what the prevalence data shows, why it took so long to be recognised, and how UK assessment, medication and support work when both are present. It is written for adults investigating themselves and for parents whose child sits somewhere on this overlap.

How the diagnostic position changed

For many years, ADHD and autism could not be diagnosed together under the dominant manuals. DSM-IV explicitly excluded an ADHD diagnosis where autism (or pervasive developmental disorder) was present. This was not because the conditions were not co-occurring; it was a rule based on a now-outdated view that the social and attentional features had to belong to one condition or the other.

DSM-5, published in 2013, removed the exclusion. ADHD and autism can be diagnosed together where the criteria for both are met, and DSM-5-TR (2022) carried that forward ^[1]. NICE NG87 for ADHD, CG142 for adult autism and CG128 for children all recognise the co-occurrence and treat them as separate, parallel diagnoses where both are present ^{[2, 3, 4]}.

This change matters because the cohort of people whose ADHD or autism was missed because the other was diagnosed first is now in their thirties, forties, fifties and beyond. Many adults presenting for assessment of one are also being assessed for the other.

How common is the co-occurrence

The exact prevalence of co-occurring ADHD and autism is hard to pin down because it depends on which population is sampled and how the diagnostic criteria are applied. Across the literature, a few anchor figures are reliable ^{[5, 8]}:

• Among autistic children and adolescents, somewhere between 30 and 50 percent meet ADHD criteria in most large samples
• Among autistic adults, the figure tends to be lower than in children, often reported around 25 to 40 percent, partly because adult ADHD presentation is harder to identify and partly because of differences in study methods
• Among children with ADHD, around 20 to 50 percent show clinically significant autistic traits, with the proportion meeting full autism criteria typically lower
• A 2019 Lancet Psychiatry systematic review and meta-analysis of co-occurring mental health diagnoses in autistic people put the pooled prevalence of ADHD in autistic populations at around 28 percent ^[8]

The range is wide because the studies use different ages, settings and assessment methods. What is consistent across the literature is that co-occurrence is far above chance, in both directions, and is not rare.

How the picture looks in real life

AuDHD is not a third condition. It is the simultaneous presentation of ADHD features and autistic features in the same person. The patterns that show up most often in clinical practice ^{[5, 6]}:

• A baseline preference for routine and predictability (autism) sitting alongside difficulty maintaining the routines (ADHD). The wanting and the doing are mismatched.
• Strong, focused interests (autism) that nonetheless rotate or burn out faster than expected (ADHD). The intensity is autistic; the impermanence is ADHD.
• Sensory sensitivity (autism) that is harder to regulate because of difficulty with attention switching and impulse control (ADHD).
• Social difficulty that is differently shaped from autism alone or ADHD alone. Autistic social difficulty tends to involve mismatch in implicit social rules and difficulty with neurotypical communication norms. ADHD social difficulty tends to involve interrupting, missing tone, low patience, distractibility in conversation. Both together produce a social picture that is harder to recognise as either alone.
• Executive function difficulties that often look more like ADHD than like autism, but that are sometimes worsened by autistic difficulty with transitions and unpredictability.
• Emotional regulation difficulty that is significant and reliable; both conditions independently affect emotional regulation, and the combination tends to produce more, not less.

This is a sketch of patterns, not a checklist. Individual people present differently, and the proportions of ADHD and autistic features vary substantially across the cohort.

Why it has often been missed

Several reasons account for why AuDHD has historically been under-recognised:

The DSM-IV exclusion

For two decades, the manuals explicitly prohibited the dual diagnosis. Clinicians trained in that era saw the patient through one lens, recorded the condition they recognised first, and the second condition went unrecorded.

Each condition can mask the other

Autistic structure can mask ADHD inattention; a person with strong autistic routines may compensate for distractibility for a long time before the routines collapse. ADHD overactivity can mask autistic withdrawal; a person who is talkative and impulsive may not be recognised as also struggling with sensory overload or social signal processing.

Female presentation is compounded

Women and girls are already underdiagnosed for both ADHD and autism individually. The combination compounds the under-recognition. Many adult women with AuDHD reach diagnosis only after years of being treated for anxiety, depression or burnout.

Late-diagnosis adults

Many adults presenting today were children before DSM-5 changed the position. Their childhood records describe one condition (or neither). Bringing the full developmental picture into a current adult assessment is part of why these assessments take time.

How a combined assessment works

Where both ADHD and autism are being considered, the assessment can be done as separate sequential assessments or as a combined assessment. The clinical content is similar either way, but the practical experience and the document trail differ. When a combined ADHD and autism assessment makes sense goes into the detail.

A combined assessment usually involves:

• A structured ADHD interview (most commonly the DIVA-5 in adults)
• A structured autism interview (such as the ADI-R, or a developmental history alongside the ADOS-2 where available)
• Symptom and trait rating scales for both
• A developmental history covering childhood and adolescent presentation
• An informant interview where possible (a parent, partner, or long-standing friend)
• Consideration of co-occurring mental health, sleep, hormonal and substance use factors

The assessment ends with a written report that addresses both conditions explicitly, even where one is not confirmed. NeuroFX offers combined ADHD and autism assessment in Bedford as the dedicated dual pathway, alongside private adult ADHD assessment and private autism assessment for single-condition pathways.

Medication and AuDHD

Medication in AuDHD is the same as medication in ADHD; there is no licensed medication for autism itself. The decision about ADHD medication is more individualised in AuDHD for a few reasons:

• Sensory profile changes can be amplified or improved on stimulants. Some autistic adults find that stimulants reduce sensory overwhelm by improving the prefrontal regulation that handles it; others find sensory experiences become harder.
• Anxiety, often higher in autistic patients, can be amplified by stimulants. Non-stimulants are sometimes the better starting point.
• Sleep and appetite, often already difficult in autism, can be more sensitive to stimulant effects.
• Interoceptive difficulty, common in autism, can affect how reliably side effects are noticed and reported. Structured tracking through titration is more useful in AuDHD than relying on the patient to notice changes spontaneously.
• The emotional regulation effect of stimulants, often a substantial benefit in ADHD, can be particularly valuable in AuDHD where regulation difficulty is compounded. Many AuDHD adults describe this as the most useful aspect of the medication.

None of this rules out stimulants in AuDHD; many AuDHD adults are well managed on standard ADHD medication. It does mean the titration is often more cautious and the medication choice more individualised. The detail is covered in the ADHD medication and prescribing with NeuroFX pathway, with the AuDHD picture explicitly considered.

AuDHD in women specifically

The female AuDHD picture deserves separate consideration. Both ADHD and autism are individually under-diagnosed in women, and the combination produces a particularly invisible profile. The classical hyperactive boy-pattern of ADHD and the classical socially withdrawn boy-pattern of autism are both poor matches for how AuDHD often presents in girls and women. The result is decades of misdiagnosis: anxiety, depression, eating disorders, borderline personality disorder, and chronic fatigue have all been recorded as primary diagnoses in women who later receive an AuDHD diagnosis.

The features that bring women in for assessment are often the combination of an autistic preference for predictability (with the routines collapsing under ADHD-related difficulty maintaining them), intense interests that rotate, social effort that is exhausting in ways that look like introversion or social anxiety, and emotional regulation difficulty that is sometimes labelled as personality difficulty. Where the developmental history fits and the current picture fits, AuDHD assessment is appropriate.

AuDHD in children and adolescents

The picture in childhood often shows up as a child who is hard to place. School identifies "something" but disagrees with itself on which something. A child may meet some ADHD criteria, some autism criteria, and not clearly meet either threshold on its own, before careful structured assessment identifies the combined presentation. Sensory profile, social communication, attentional regulation and executive function all need consideration; an assessment that focuses on one and skips the others can miss the dual picture.

For families, the recognition of AuDHD often resolves a long-running puzzle. Adjustments in school, sensory accommodations at home, and any indicated medication tend to be more effective when the full picture is named.

What happens after diagnosis

AuDHD diagnosis is not the end of the assessment process; it is the start of the support process. The practical pathway typically includes:

• Psychoeducation about both conditions and how they interact for this particular person
• Reasonable adjustments at work or school under the Equality Act 2010
• Where appropriate, ADHD medication initiated under specialist supervision
• Sensory and structural support that recognises both
• Therapy where indicated, ideally with a clinician familiar with both conditions
• Peer community where it helps; AuDHD-specific community has grown substantially

The diagnosis itself often reframes years of self-understanding. Many adults describe a period of grief and relief together: grief for the years where the picture was misread, relief that there is a coherent explanation. This is a normal part of the process.

Support and adjustments

The day-to-day picture in AuDHD often benefits from a combination that neither single-condition framework fully covers. Practical examples ^{[3, 4, 5]}:

• Reasonable adjustments at work that account for both predictability needs (autism) and stimulation needs (ADHD)
• A sensory profile assessment, where useful, alongside ADHD treatment
• Sleep support, which often needs both ADHD-aware (timing, stimulation) and autism-aware (sensory, routine) elements
• Therapy that recognises both, rather than treating one and assuming the other will resolve
• Peer community support where it helps; AuDHD-specific community resources have grown substantially in recent years

What this means in practice

• ADHD and autism co-occur often. AuDHD is the community term, now used clinically, for the simultaneous presentation.
• Co-occurrence rates are typically reported around 30 to 50 percent in autistic populations and 20 to 50 percent for autistic traits in ADHD populations, with full dual diagnosis lower than either trait estimate.
• DSM-5 (2013) removed the long-standing exclusion that prevented dual diagnosis; DSM-5-TR and NICE guidance carry that forward.
• The presentation is its own picture, not a sum of two checklists. Patterns include mismatch between desired routine and ability to maintain it, intense but rotating interests, and compounded executive function and emotional regulation difficulty.
• Combined assessment is available in the UK as a single pathway or as sequential single-condition assessments.

When to speak to a professional

Speak to your GP if you suspect AuDHD in yourself or your child. NHS routes for ADHD and autism assessment are usually separate; Right to Choose in England applies to ADHD assessment and, in some areas, autism assessment. NeuroFX offers private ADHD and autism assessment for adults and children aged 6 and upwards, including dedicated combined assessment pathways where the dual picture is clear from the start. Seek urgent help via 111, 999 or A&E for any acute mental health crisis.

Sources

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022.
2. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87
3. NICE. Autism spectrum disorder in adults: diagnosis and management. CG142. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/cg142
4. NICE. Autism spectrum disorder in under 19s: recognition, referral and diagnosis. CG128. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/cg128
5. Hours C, Recasens C, Baleyte JM. ASD and ADHD Comorbidity: What Are We Talking About? Frontiers in Psychiatry. 2022;13:837424.
6. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
7. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910.
8. Lai MC, Kassee C, Besney R, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):819-829.